元认知疗法与工作导向干预对因焦虑和抑郁休病假患者的效果:一项随机对照等待列表试验的研究方案
本研究为随机对照等待列表试验(N=240),在挪威一家门诊机构纳入因抑郁和焦虑休病假的患者,干预组立即接受方案化元认知疗法(MCT)和工作导向干预,对照组为等待列表,所有患者最多接受12次每周治疗;共同主要结局为治疗结束时重返工作(RTW)变化及抑郁焦虑症状变化,并将进行成本效果分析。
要点
- 首个针对因焦虑和抑郁休病假患者评估MCT联合工作导向干预的随机对照试验。
- 干预组立即接受MCT与工作导向干预,对照组为等待列表,所有患者最多12次每周治疗。
- 共同主要结局为治疗结束时RTW变化及抑郁焦虑症状变化,并开展成本效果分析。
核心结论
- 本研究旨在探讨元认知疗法和工作导向干预对因抑郁和焦虑休病假患者减轻症状和提高RTW率的有效性。
- 作者认为该研究是该领域首个针对因焦虑和抑郁休病假患者的MCT与工作导向干预随机对照试验。
研究设计与样本
- 随机对照等待列表试验,计划样本量N=240。
- 干预组在纳入后立即接受方案化元认知疗法(MCT)和工作导向干预,对照组为等待列表对照组。
- 所有患者最多接受12次每周治疗。
- 研究场景为挪威一家门诊机构,该机构属于旨在减少病假的全国性项目的一部分。
主要发现
- 共同主要结局为治疗结束时重返工作(RTW)变化以及抑郁和焦虑症状变化。
- 除自我报告外,还将从国家登记处收集干预前2年至干预后4年的病假数据。
- 症状评分将通过自我报告在治疗前、治疗后以及治疗后6个月和12个月随访时收集。
- 成本效果分析将使用总成本和质量调整生命年作为次要结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Common mental disorders such as depression and anxiety are major contributors to the global burden of disease. Affected individuals suffer reduced quality of life, impaired functioning and reduced capacity to work. Maintaining employment is an important determinant for health and wellbeing, and the economic impact of depression and anxiety is a significant societal expense. Treatments providing effective symptom reduction and helping patients return to work (RTW) would thus have substantial public health benefits. The present study will explore the effectiveness of metacognitive therapy (MCT) and work-focused interventions on reducing symptoms and increasing RTW rates for patients on sick leave due to depression and anxiety. METHODS: The study is a randomised controlled wait-list trial (RCT; N = 240). The intervention group will receive protocol-based MCT and work-focused interventions immediately after inclusion. The control condition is a wait-list control group. All patients will receive up to 12 weekly sessions. The study context is a Norwegian outpatient clinic part of a national programme aimed at reducing sick leave. The co-primary outcomes are change in RTW and symptoms of depression and anxiety at the end of treatment. In addition to self-report, sick leave will also be collected from national registries from 2 years prior to intervention to 4 years after intervention. Symptoms of scores will be collected by self-report at pre- and post-treatment and at 6 and 12 months follow-up after treatment. A cost-effectiveness analysis will use total cost and quality-adjusted life-years as the secondary outcomes. DISCUSSION: There is broad consensus on the importance of identifying treatment that effectively reduces depression and anxiety symptoms and aids RTW. This study is an important contribution to the field as it is the first RCT on MCT and work-focused interventions for patients on sick leave due to anxiety and depression. TRIAL REGISTRATION: ClinicalTrials.gov NCT03301922 . Registered on October 4, 2017.
引用
- Sandin K, Gjengedal RGH, Osnes K, et al. Metacognitive therapy and work-focused interventions for patients on sick leave due to anxiety and depression: study protocol for a randomised controlled wait-list trial. Trials. 2021. PMID: 34838125. doi:10.1186/s13063-021-05822-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。